Drug
Indiplon
Indiplon: highest development phase Phase 3, developed by Neurocrine Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Neurocrine Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Indiplon NCT00232167 | Phase 3 | Insomnia |
Latest
No recent events.
Follow Indiplon on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.